| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30000369 | HIV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS30001137 | HIV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS30056688 | HIV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS30056689 | HIV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS30056690 | HIV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS20057283 | HPV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS20027132 | HPV | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
| TVIS44000435 | HTLV-1 | ENSG00000168036.19 | protein_coding | CTNNB1 | Yes | No | 1499 | B4DGU4 P35222 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CTNNB1 |
|---|---|
| DrugBank ID | DB03904 |
| Drug Name | Urea |
| Target ID | BE0000985 |
| UniProt ID | P35222 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 10592235 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Approved; Investigational |
| Direct Classification | Ureas |
| SMILES | NC(N)=O |
| Pathways | Citrullinemia Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Metolazone Action Pathway; Bumetanide Action Pathway; D-Arginine and D-Ornithine Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Polythiazide Action Pathway; Trichlormethiazide Action Pathway; Hyperprolinemia Type II; Hartnup Disorder; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Indapamide Action Pathway; Torsemide Action Pathway; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Hydrochlorothiazide Action Pathway; Triamterene Action Pathway; Lysinuric Protein Intolerance; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Eplerenone Action Pathway; Hyperprolinemia Type I; Glucose Transporter Defect (SGLT2); Arginine and Proline Metabolism; Methyclothiazide Action Pathway; Cystinuria; Spironolactone Action Pathway; Blue Diaper Syndrome; Furosemide Action Pathway; Quinethazone Action Pathway |
| PharmGKB | PA451831 |
| ChEMBL | CHEMBL985 |
